GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.
Battling Alzheimer's: A New Hope on the Horizon
Alzheimer's Disease. The very name evokes a sense of dread, a long, slow fading of memory, personality, and ultimately, life itself. It's a condition that not only devastates those who suffer from it but also places an immense emotional and physical burden on their families and caregivers. For years, the scientific and medical communities have been locked in a relentless battle against this formidable foe, striving to understand its origins, slow its progression, and ideally, find a cure.
Triumphant Return: Judge Orders FDA to Restore Vital Clinical Trial Diversity Webpages, Empowering Health Equity!
It is a truly hopeful and significant development in the realm of healthcare and government transparency that a US District Judge has recently ordered the full reinstatement of crucial healthcare resources, including vital webpages dedicated to clinical trial diversity, by the US Food and Drug Administration (FDA) and the Department of Health and Human Services
Stay Steady, Stay Safe: The Ultimate Guide to Preventing Falls and Fractures as You Age
For many older adults, a simple everyday mishap—like slipping on a wet floor or tripping over a rug—can instantly become a life-altering event. Falls are not just common; they are a significant threat to long-term health, mobility, and independence. Every year, thousands of older adults experience broken bones due to falls.
Bridging the Gap: How Glassbury AI is Making Medical Research Work for Everyone
At Glassbury AI, we believe health justice starts with inclusion. We are using modern technology to fix this recruitment crisis by building trust and making the process easy to understand for every family.
The Regulatory Shift: From Optional Inclusion to Mandatory Action
Learn how Glassbury AI bridges grassroots engagement and LLM companions to meet FDA Diversity Action Plan compliance and solve Alzheimer's trial enrollment.
The Real Cost of Memory Loss: Caregivers and Clinical Trial Diversity Matter
Learn about the true economic and social impact of Alzheimer's, the burden on unpaid caregivers, and why diversity in medical research is key to a cure.